Drug-coated balloons and drug-eluting stents: clinical effectiveness revisited

Area of Science:

• Vascular Surgery
• Interventional Cardiology
• Peripheral Arterial Disease Management

Background:

• Critical limb ischemia (CLI) is a severe manifestation of peripheral arterial disease (PAD).
• CLI leads to significant morbidity, including ischemic rest pain, ulcerations, gangrene, and tissue loss.
• Advanced endovascular techniques are crucial for managing CLI and improving patient outcomes.

Purpose of the Study:

• To review recent trials and studies on the clinical effectiveness of drug-eluting devices for CLI treatment.
• To investigate the role of advanced endovascular techniques like retrograde recanalization.
• To assess the correlation between vessel patency and clinical outcomes in CLI patients.

Main Methods:

• Systematic review of recent clinical trials and studies.
• Analysis of data on drug-eluting stents and balloons in CLI treatment.
• Evaluation of outcomes including limb salvage, ulcer healing, and Rutherford class improvement.

Main Results:

• Drug-eluting devices show promise in improving vessel patency and clinical outcomes for CLI.
• Advanced endovascular techniques, including retrograde recanalization, enhance treatment success rates.
• The precise correlation between sustained vessel patency and long-term clinical benefits requires further investigation.

Conclusions:

• Drug-eluting stents and balloons represent a significant advancement in the endovascular treatment of CLI.
• These devices offer potential for improved limb salvage and symptom relief in patients with severe PAD.
• Further research is needed to fully elucidate the long-term efficacy and optimal use of these technologies in CLI management.